Gregory A. Demopulos,Kenneth M. Ferguson,William Joseph Lambert,John Steven Whitaker
申请号：
US15691266
公开号：
US20180153988A1
申请日:
2017.08.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.
